US 12264366
Genome-based methods for reducing cardiovascular risk
granted A61KA61K2039/505
Quick answer
US patent 12264366 (Genome-based methods for reducing cardiovascular risk) held by REGENERON PHARMACEUTICALS, INC. expires Mon Mar 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Apr 01 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61K, A61K2039/505